[EN] NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE BROMODOMAINE
申请人:RVX THERAPEUTICS INC
公开号:WO2014096965A2
公开(公告)日:2014-06-26
The present disciosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.